UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

Haematologica (Roma), 2014-06, Vol.99 (6), p.1041-1049

2014

Volltextzugriff (PDF)

Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society

Acta clinica belgica (English ed. Online), 2022-04, Vol.77 (2), p.470-483

2022

Volltextzugriff (PDF)

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

Clinical infectious diseases, 2002-01, Vol.34 (1), p.7-14

2002

Volltextzugriff (PDF)

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2014-07, Vol.49 (7), p.865-872

2014

Volltextzugriff (PDF)

Parvovirus B19-triggered hemophagocytic lymphohistiocytosis in a patient with Crohn’s disease

Acta gastro-enterologica belgica, 2022-07, Vol.85 (3), p.522-524

2022

Volltextzugriff (PDF)

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes

Annals of oncology, 2014-02, Vol.25 (2), p.447-454

2014

Volltextzugriff (PDF)

Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias

Leukemia, 2004-04, Vol.18 (4), p.734-742

2004

Volltextzugriff (PDF)

Phase II study of haploidentical stem cell transplantation using ex vivo photodepletion of donor lymphocyte infusions to eliminate anti-host reactivity results in low relapse rates and high survival rates: Final 2 year follow-up

Cytotherapy (Oxford, England), 2018-05, Vol.20 (5), p.S10-S11

2018

Volltextzugriff (PDF)

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization

Bone marrow transplantation (Basingstoke), 2012-08, Vol.47 (8), p.1046-1050

2012

Volltextzugriff (PDF)

A single dose of donor lymphocytes depleted of anti-host reactive T cells (ATIR101) following T-cell-depleted haploidentical HSCT is safe and efficaceous

CYTOTHERAPY, 2019-05, Vol.21 (5), p.S20-S21

2019

Volltextzugriff (PDF)

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole

European journal of clinical microbiology & infectious diseases, 2012-06, Vol.31 (6), p.1173-1179

2012

Volltextzugriff (PDF)

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Blood, 2006-11, Vol.108 (9), p.2928-2936

2006

Volltextzugriff (PDF)

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

The New England journal of medicine, 2020-12, Vol.383 (26), p.2526-2537

2020

Volltextzugriff (PDF)

Evaluation of Serum Sandwich Enzyme-Linked Immunosorbent Assay for Circulating Galactomannan during Caspofungin Therapy: Results from the Caspofungin Invasive Aspergillosis Study

Clinical infectious diseases, 2005-07, Vol.41 (1), p.e9-e14

2005

Volltextzugriff (PDF)

P768: GUADECITABINE (SGI‐110) VS. TREATMENT CHOICE (TC) IN RELAPSED/REFRACTORY(R/R) MYELODYSPLASTIC SYNDROME (MDS), RESULTS OF A GLOBAL, RANDOMIZED, PHASE 3 STUDY

HemaSphere, 2022-06, Vol.6, p.663-664

2022

Volltextzugriff (PDF)

Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia

Current medical research and opinion, 2015-01, Vol.31 (1), p.35-42

2015

Volltextzugriff (PDF)

P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B‐ALL IN ADULTS. A PHASE II HOVON TRIAL

HemaSphere, 2022-06, Vol.6, p.266-267

2022

Volltextzugriff (PDF)

An EORTC International Multicenter Randomized Trial (EORTC Number 19923) Comparing Two Dosages of Liposomal Amphotericin B for Treatment of Invasive Aspergillosis

Clinical infectious diseases, 1998-12, Vol.27 (6), p.1406-1412

1998

Volltextzugriff (PDF)

Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing

Bone marrow transplantation (Basingstoke), 2001-09, Vol.28 (5), p.511-518

2001

Volltextzugriff (PDF)

P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG‐TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML‐001 TRIAL OF ORAL AZACITIDINE

HemaSphere, 2022-06, Vol.6, p.397-398

2022

Volltextzugriff (PDF)

High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial

Journal of clinical oncology, 2014-01, Vol.32 (3), p.219-228

2014

Volltextzugriff (PDF)

PHASE 2 STUDY OF PEVONEDISTAT + AZACITIDINE VERSUS AZACITIDINE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES/CHRONIC MYELOMONOCYTIC LEUKEMIA OR LOW-BLAST ACUTE MYELOGENOUS LEUKEMIA (NCT02610777)

Hematology, Transfusion and Cell Therapy, 2020-11, Vol.42, p.285-286

2020

Volltextzugriff (PDF)

1 – 25 von 165

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

Englisch
(165)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(86)
Science & Technology
(86)
Humans
(81)
Female
(57)
Male
(53)
Hematology
(52)
Middle Aged
(52)
Biological And Medical Sciences
(47)
Medical Sciences
(47)
Adult
(45)
Aged
(39)
Oncology
(29)
Medicin Och Hälsovetenskap
(24)
Treatment Outcome
(23)
Hematologic And Hematopoietic Diseases
(22)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(21)
Aged, 80 And Over
(20)
General & Internal Medicine
(20)
Medicine, General & Internal
(20)
Adolescent
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

Parvovirus B19-triggered hemophagocytic lymphohistiocytosis in a patient with Crohn’s disease

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes

Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

Phase II study of haploidentical stem cell transplantation using ex vivo photodepletion of donor lymphocyte infusions to eliminate anti-host reactivity results in low relapse rates and high survival rates: Final 2 year follow-up

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization

A single dose of donor lymphocytes depleted of anti-host reactive T cells (ATIR101) following T-cell-depleted haploidentical HSCT is safe and efficaceous

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Evaluation of Serum Sandwich Enzyme-Linked Immunosorbent Assay for Circulating Galactomannan during Caspofungin Therapy: Results from the Caspofungin Invasive Aspergillosis Study

P768: GUADECITABINE (SGI‐110) VS. TREATMENT CHOICE (TC) IN RELAPSED/REFRACTORY(R/R) MYELODYSPLASTIC SYNDROME (MDS), RESULTS OF A GLOBAL, RANDOMIZED, PHASE 3 STUDY

Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia

P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B‐ALL IN ADULTS. A PHASE II HOVON TRIAL

An EORTC International Multicenter Randomized Trial (EORTC Number 19923) Comparing Two Dosages of Liposomal Amphotericin B for Treatment of Invasive Aspergillosis

P699: REAL‐LIFE OUTCOMES OF PONATINIB TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) OR PHILADELPHIA CHROMOSOME‐POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL): 5‐YEAR‐DATA FROM A BELGIAN REGISTRY

Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing

P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG‐TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML‐001 TRIAL OF ORAL AZACITIDINE

High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

PHASE 2 STUDY OF PEVONEDISTAT + AZACITIDINE VERSUS AZACITIDINE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES/CHRONIC MYELOMONOCYTIC LEUKEMIA OR LOW-BLAST ACUTE MYELOGENOUS LEUKEMIA (NCT02610777)

Suchergebnisse filtern